Abstract Schizophrenia is a long-term, lifelong chronic disease that requires sustained treatment. In recent years, cognitive behavioral therapy (CBT) for patients with schizophrenia has attracted significant clinical attention. However, research remains limited regarding its application in non-Western cultures. Schizophrenia has become a prominent health problem in China, yet it remains unclear to what extent CBT can work effectively within the Chinese psychiatric hospital system. This study summarizes the most up-to-date evidence on the effectiveness of CBT in patients with schizophrenia in China. A systematic review was conducted, and eight studies were ultimately included. The findings suggest that brief formats of CBT and mindfulness-psychoeducation are promising options to supplement the usual care of schizophrenia in China. Further clinical trials are necessary to provide a more robust statistical synthesis in this field.
Introduction
Schizophrenia affects approximately 1% of the global population and is characterized by a range of cognitive, behavioral, and emotional dysfunctions. In China, the prevalence and management of schizophrenia have become critical public health priorities. While pharmacological treatments (antipsychotics) and physical therapies like Electroconvulsive Therapy (ECT) remain the standard of care, they often fail to address the complex psychosocial needs of patients, such as social reintegration and "insight"—the patient's awareness of their own condition.
Cognitive Behavioral Therapy (CBT) is a well-established psychosocial intervention in Western medicine, known for its efficacy in managing psychotic symptoms. However, its effectiveness in non-Western, specifically Chinese, psychiatric settings has historically been less clear. This review addresses this gap by synthesizing recent clinical trials to determine if CBT can be successfully adapted to the Chinese healthcare system to improve long-term outcomes.
Methodology
This systematic review was conducted in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines to ensure transparency and rigor.
Search Strategy and Selection
The authors queried four major databases—PubMed, PsycINFO, Medline, and a supplementary search—for studies published up to October 2021. Inclusion criteria required that studies be clinical trials focused on schizophrenia treatment in mainland China, Hong Kong, Macau, or Taiwan, with interventions explicitly identified as CBT.
Synthesis Approach
Due to the heterogeneity of the delivery methods and outcome measures across the included studies, the authors performed a qualitative synthesis rather than a quantitative meta-analysis. The interventions were categorized into three primary types:
- Brief/Group CBT: Focused on symptom management in shorter durations.
- Mindfulness-based Psychoeducation: Integrating meditative practices with illness education.
- Integrated Care: Combining medication, CBT, and social rehabilitation.
Evidence from Clinical Trials
The review evaluated eight specific clinical trials that met the inclusion criteria, representing a diverse range of clinical settings:
- Li et al. (2015): A multicenter trial involving 192 patients.
- Liu et al. (2019): Focused specifically on first-episode schizophrenia (FES).
- Guo et al. (2017): A community-based study in Beijing involving 220 individuals.
- Wong et al. (2019): Evaluated group-based CBT for psychosis (CBTp).
- Chien et al. (2014/2019): Multisite trials investigating mindfulness-based psychoeducation.
- She et al. (2017): Evaluated a "two-stage integrated care" model.
- Li et al. (2018): A community-based comprehensive intervention conducted in Guangzhou.
Key Insights and Cultural Adaptations
The Efficacy of "Brief" Formats
Traditional CBT can be resource-intensive, often requiring 20 or more sessions. The review highlights that "brief" CBT (approximately 10 sessions) is particularly effective in Chinese community settings. This format proved successful in managing positive symptoms, such as delusions and hallucinations, and was instrumental in preventing relapse.
Mindfulness and Neuroplasticity
Mindfulness-based psychoeducation emerged as a standout intervention. Beyond behavioral improvements, one study noted increases in gray matter volume and density in brain regions associated with attention and emotional control following therapy. This suggests that mindfulness may offer neurobiological benefits alongside psychological ones.
Improving Patient Insight
A significant hurdle in schizophrenia treatment is the patient's lack of awareness regarding their illness. The reviewed studies consistently demonstrated that CBT helped patients better understand their condition, which directly correlated with improved medication adherence and better long-term prognosis.
Addressing Social Stigma
In the Chinese cultural context, internalized stigma and social discrimination are major barriers to recovery. Integrated care models that include CBT were found to reduce the degree of psychological distress related to social discrimination, helping patients navigate their communities with greater confidence.
Quantitative Results
- Clinical Response Rates: In the community study by Guo et al., 37.3% of patients receiving brief CBT plus standard care showed a clinically significant response, compared to only 19.1% in the standard care group ($P = 0.003$).
- Symptom Reduction: In group CBT settings, nearly 61% of participants experienced a 50% reduction in their delusion (illusion) scores.
- Long-term Maintenance: Mindfulness-based groups showed significantly better functioning and fewer hospital readmissions over a 24-month follow-up period compared to routine care, with moderate to large effect sizes (Cohen’s $d = 0.49–0.98$).
- Relapse Prevention: Integrated care models combining medication, CBT, and rehabilitation resulted in significantly lower relapse risks ($p=0.012$) than medication-only groups.
Limitations and Future Directions
Despite the positive findings, the authors identified several limitations in the current body of research:
- Small Study Sample: Only eight studies met the rigorous inclusion criteria, preventing a formal statistical meta-analysis.
- Follow-up Gaps: Many studies lacked long-term follow-up (beyond 24 months), making it difficult to confirm the permanence of CBT's benefits.
- Generalizability: The limited number of studies makes it difficult to generalize results across China’s vast and diverse demographic landscape.
Conclusion
This systematic review provides evidence that CBT, particularly when adapted into brief or mindfulness-based formats, is a highly effective supplemental treatment for schizophrenia in China. By improving patient insight and social functioning while reducing relapse rates, CBT addresses critical gaps left by pharmacological treatment alone. The authors call for more large-scale, longitudinal clinical trials to provide the statistical power needed for a definitive global synthesis of CBT's impact in non-Western cultures.
Summary updated